1. A revised 1000 year atmospheric δ13C‐CO2 record from Law Dome and South Pole, Antarctica. Issue 15 (15th August 2013) Authors: Rubino, M.; Etheridge, D. M.; Trudinger, C. M.; Allison, C. E.; Battle, M. O.; Langenfelds, R. L.; Steele, L. P.; Curran, M.; Bender, M.; White, J. W. C.; Jenk, T. M.; Blunier, T.; Francey, R. J. Journal: Journal of geophysical research Issue: Volume 118:Issue 15(2013) Page Start: 8482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluating steady-state resting energy expenditure using indirect calorimetry in adults with overweight and obesity. Issue 7 (July 2020) Authors: Popp, C.J.; Butler, M.; Curran, M.; Illiano, P.; Sevick, M.A.; St-Jules, D.E. Journal: Clinical nutrition Issue: Volume 39:Issue 7(2020) Page Start: 2220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0271 Modular Analysis of Peripheral Blood Gene Expression in Rheumatoid Arthritis Captures Reproducible Gene Expression Changes in TNF Responders. (10th June 2014) Authors: Curran, M.; Oswald, M.; Lee, A.; Cherkas, Y.; Brodmerkel, C.; Lamberth, S.; Gregersen, P.K. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0573 Development of a Pediatric Rheumatology Education Resource-Sharing Website: If You Build it, Will they Come?. (9th June 2015) Authors: Curran, M.; Singh, R. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0009 Serum 14-3-3 ETA Is An RA Specific Mechanistic Marker. (15th July 2016) Authors: Dasgupta, B.; Cherkas, Y.; Lamberth, S.; Hayden, K.; Brodmerkel, C.; Marotta, A.; Curran, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0182 Improvement in Measures of Depressed Mood and Anhedonia, and Fatigue, In a Randomized, Placebo-Controlled, Phase 2 Study of Sirukumab, A Human Anti-Interleukin-6 Antibody, In Patients with Rheumatoid Arthritis. (9th June 2015) Authors: Hsu, B.; Wang, D.; Sun, Y.; Salvadore, G.; Singh, J.; Curran, M.; Caers, I.; Drevets, W.; Wittenberg, G.; Chen, G. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0105 Effect of sirukumab on hepcidin levels and markers of anemia: Results of a phase 2B trial in patients with active rheumatoid arthritis despite methotrexate therapy. (23rd January 2014) Authors: Toedter, G.; Sague, S.; Wu, X.; Curran, M.; Hsu, B. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Practice‐based differences in paediatric discoid lupus erythematosus. (23rd June 2019) Authors: Arkin, L.M.; Buhr, K.; Brandling‐Bennett, H.; Chiu, Y.; Chong, B.; Curran, M.; Hunt, R.; Paller, A.S.; Werth, V.P.; Klein‐Gitelman, M.; von Scheven, E.; Ardalan, K. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: 805 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP0027 Identification of Molecular Disease Drivers Using eQTLS Derived from a Cohort of Rheumatoid Arthritis Patients. (9th June 2015) Authors: Walsh, A.; Whitaker, J.W.; Huang, C.C.; Cherkas, Y.; Lamberth, S.; Brodmerkel, C.; Curran, M.; Dobrin, R. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0038 Pharmacodynamic Effect of Intravenous Golimumab by Messenger RNA Expression Profiling. (10th June 2014) Authors: Cherkas, Y.; Brodmerkel, C.; Curran, M.; Lamberth, S. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗